Balak Salesh 4
4 · UNIVERSAL BIOSENSORS INC · Filed Dec 23, 2020
Insider Transaction Report
Form 4
Balak Salesh
Chief Financial Officier
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2020-12-11−40,000→ 0 totalExercise: $0.00Exp: 2020-12-11→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2020-12-11+40,000→ 266,558 total
Holdings
- 721,000
Stock Option (Right to Buy)
Exercise: $0.50Exp: 2023-04-20→ Common Stock (721,000 underlying) - 500,000
Stock Option (Right to Buy)
Exercise: $0.30Exp: 2025-03-24→ Common Stock (500,000 underlying) - 216,300
Stock Option (Right to Buy)
Exercise: $0.50Exp: 2024-02-27→ Common Stock (216,300 underlying) - 40,000
Stock Option (Right to Buy)
Exercise: $0.00Exp: 2022-01-29→ Common Stock (40,000 underlying)
Footnotes (7)
- [F1]Includes (i) 262,392 shares in the form of CDIs Mr. Balak holds directly and (ii) 4,166 restricted fully paid shares.
- [F2]The price reported is stated in Australian dollars.
- [F3]The options are fully vested but can only be exercised after 03/01/2021.
- [F4]206,000 of the stock options vested and became exercisable on 10/05/2016, 412,000 of the stock options vested and became exercisable on 12/31/2016 and 103,000 of the stock options vested and became exercisable on 02/23/2017.
- [F5]216,300 stock options vested and became exercisable on 12/31/2017.
- [F6]13,333 stock options vested and became exercisable on 12/31/2015, 13,333 stock options vested and became exercisable on 12/31/2016, and 13,334 stock options vested and became exercisable on 12/31/2017.
- [F7]13,333 stock options vested and became exercisable on 12/31/2014, 13,333 stock options vested and became exercisable on 12/31/2015, and 13,334 stock options vest and become exercisable on 12/31/2016. These options were exercised on 12/11/2020.